查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1642423

止咳药市场 - 全球产业分析、规模、占有率、成长、趋势及2032年预测

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 179 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球咳嗽药市场规模上升，预计到2025年将激增至 287.5亿美元，到2032年将进一步成长至 443.8亿美元。这种扩张是由于呼吸系统疾病的增加、消费者意识的增强以及药物解决方案的进步，年复合成长率为 6.4%。

止咳药是指处方用来减轻咳嗽衝动的药物。这些药物透过影响大脑的咳嗽反射来发挥作用，有助于缓解呼吸道感染、过敏原和环境污染物引起的症状。市场经历一波创新浪潮，包括新的药物组合和增强的给药机制，目的是提高患者的便利性和治疗效果。

随着消费者健康意识的增强，非处方（OTC）止咳药的需求也随之增加。由于污染、季节性感染、过敏原等原因导致的呼吸系统疾病的流行推动市场扩张。消费者积极寻求治疗持续咳嗽的有效方法，推动了止咳产品的销售。公司优先开发能够提高疗效并减少副作用的配方。市场转向整合多种活性成分的联合疗法，以提供全面的缓解。较方便的剂型，如液体胶囊、锭剂和喷雾剂，越来越受到消费者的欢迎。

本报告研究了全球咳嗽药市场，并提供了市场概述以及有关市场类型、药物类型、配方、通路、区域趋势和参与市场的公司竞争动态的资讯。

目录

第1章 执行摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE 分析

第3章 定价分析，2019-2023年

第4章 2019年至2032年全球止咳药市场展望

  • 2019年至2032年全球止咳药市场展望，依类型、价值（十亿美元）、数量（单位）
  • 2019年至2032年全球止咳药市场展望，依药物类型、价值（十亿美元）、数量（单位）
  • 2019年至2032年全球咳嗽药市场展望，依配方、价值（十亿美元）和数量（单位）
  • 2019年至2032年全球咳嗽药市场展望，依通路、价值（十亿美元）和数量（单位）
  • 2019年至2032年全球咳药市场展望，依地区、价值（十亿美元）、数量（单位）

第5章 2019年至2032年北美止咳药市场展望

第6章 2019年至2032年欧洲止咳药市场展望

第7章 2019-2032年亚太地区止咳药市场展望

第8章 2019-2032年拉丁美洲咳嗽药市场展望

第9章 2019年至2032年中东、非洲止咳药市场展望

第10章 竞争格局

  • 依类型和依药物划分的热图
  • 2024年公司市场占有率分析
  • 竞争资讯中心
  • 公司简介
    • Abbott Laboratories
    • Acella Pharmaceuticals, LLC
    • GlaxoSmithKline Plc
    • Johnson & Johnson services Inc.
    • Merck KGaA
    • Novartis International AG
    • Pfizer Inc.
    • Procter & Gamble

第11章 附录

简介目录

The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.

Market Dynamics

Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.

Growth Drivers

Increasing Health Consciousness & Respiratory Conditions

  • A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
  • The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
  • Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.

Innovation & Expansion in Product Offerings

  • Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
  • The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
  • More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.

Business Opportunities

Development of Pediatric-Specific Products

  • Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
  • Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.

Demand for Natural & Herbal Cough Remedies

  • The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
  • Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.

Market Challenges

Regulatory Constraints

  • Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
  • Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.

Supply Chain Issues

  • Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
  • Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
  • Companies must adopt resilient supply chain strategies to maintain consistent distribution.

Regional Insights

Europe: Market Leader

  • The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
  • Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
  • A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.

South Asia & Pacific: Fastest-Growing Market

  • Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
  • Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
  • A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.

Leading Market Players

The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:

  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

Noteworthy Developments

New Product Introductions

  • 2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
  • Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.

Strategic Acquisitions

  • 2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
  • Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.

Market Segmentation

The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.

By Type:

  • Acute Cough
  • Chronic Cough

By Active Ingredients:

  • Dextromethorphan
  • Codeine
  • Butramirate
  • Benzonatate
  • Others

By Form:

  • Tablets/Capsules
  • Liquid Syrups
  • Sprays

By Sales Channels:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • E-commerce Platforms

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cough Suppressant Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Cough Suppressant Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Cough Suppressant Market Outlook, 2019 - 2032

  • 4.1. Global Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Acute Cough
      • 4.1.1.2. Chronic Cough
  • 4.2. Global Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dextromethorphan
      • 4.2.1.2. Codeine
      • 4.2.1.3. Butramirate
      • 4.2.1.4. Bennzonatate
      • 4.2.1.5. Others
  • 4.3. Global Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Solid
      • 4.3.1.2. Liquid
      • 4.3.1.3. Spray
  • 4.4. Global Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Retail Pharmacies
      • 4.4.1.3. Drug Stores
      • 4.4.1.4. Online Pharmacies
  • 4.5. Global Cough Suppressant Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Cough Suppressant Market Outlook, 2019 - 2032

  • 5.1. North America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Acute Cough
      • 5.1.1.2. Chronic Cough
  • 5.2. North America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dextromethorphan
      • 5.2.1.2. Codeine
      • 5.2.1.3. Butramirate
      • 5.2.1.4. Bennzonatate
      • 5.2.1.5. Others
  • 5.3. North America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Solid
      • 5.3.1.2. Liquid
      • 5.3.1.3. Spray
  • 5.4. North America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Retail Pharmacies
      • 5.4.1.3. Drug Stores
      • 5.4.1.4. Online Pharmacies
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.2. U.S. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.3. U.S. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.4. U.S. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.5. Canada Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.6. Canada Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.7. Canada Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.8. Canada Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Cough Suppressant Market Outlook, 2019 - 2032

  • 6.1. Europe Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Acute Cough
      • 6.1.1.2. Chronic Cough
  • 6.2. Europe Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dextromethorphan
      • 6.2.1.2. Codeine
      • 6.2.1.3. Butramirate
      • 6.2.1.4. Bennzonatate
      • 6.2.1.5. Others
  • 6.3. Europe Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Solid
      • 6.3.1.2. Liquid
      • 6.3.1.3. Spray
  • 6.4. Europe Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Retail Pharmacies
      • 6.4.1.3. Drug Stores
      • 6.4.1.4. Online Pharmacies
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.2. Germany Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.3. Germany Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.4. Germany Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.5. U.K. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.6. U.K. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.7. U.K. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.8. U.K. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.9. France Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.10. France Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.11. France Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.12. France Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.13. Italy Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.14. Italy Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.15. Italy Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.16. Italy Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.17. Turkey Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.18. Turkey Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.19. Turkey Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.20. Turkey Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.21. Russia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.22. Russia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.23. Russia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.24. Russia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.25. Rest of Europe Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.26. Rest of Europe Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.27. Rest of Europe Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.28. Rest of Europe Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Cough Suppressant Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Acute Cough
      • 7.1.1.2. Chronic Cough
  • 7.2. Asia Pacific Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dextromethorphan
      • 7.2.1.2. Codeine
      • 7.2.1.3. Butramirate
      • 7.2.1.4. Bennzonatate
      • 7.2.1.5. Others
  • 7.3. Asia Pacific Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Solid
      • 7.3.1.2. Liquid
      • 7.3.1.3. Spray
  • 7.4. Asia Pacific Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Retail Pharmacies
      • 7.4.1.3. Drug Stores
      • 7.4.1.4. Online Pharmacies
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.2. China Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.3. China Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.4. China Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.5. Japan Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.6. Japan Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.7. Japan Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.8. Japan Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.9. South Korea Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.10. South Korea Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.11. South Korea Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.12. South Korea Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.13. India Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.14. India Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.15. India Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.16. India Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.17. Southeast Asia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.18. Southeast Asia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.19. Southeast Asia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.20. Southeast Asia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Cough Suppressant Market Outlook, 2019 - 2032

  • 8.1. Latin America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Acute Cough
      • 8.1.1.2. Chronic Cough
  • 8.2. Latin America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dextromethorphan
      • 8.2.1.2. Codeine
      • 8.2.1.3. Butramirate
      • 8.2.1.4. Bennzonatate
      • 8.2.1.5. Others
  • 8.3. Latin America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Solid
      • 8.3.1.2. Liquid
      • 8.3.1.3. Spray
  • 8.4. Latin America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Retail Pharmacies
      • 8.4.1.3. Drug Stores
      • 8.4.1.4. Online Pharmacies
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.2. Brazil Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.3. Brazil Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.4. Brazil Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.5. Mexico Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.6. Mexico Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.7. Mexico Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.8. Mexico Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.9. Argentina Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.10. Argentina Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.11. Argentina Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.12. Argentina Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Cough Suppressant Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Acute Cough
      • 9.1.1.2. Chronic Cough
  • 9.2. Middle East & Africa Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dextromethorphan
      • 9.2.1.2. Codeine
      • 9.2.1.3. Butramirate
      • 9.2.1.4. Bennzonatate
      • 9.2.1.5. Others
  • 9.3. Middle East & Africa Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Solid
      • 9.3.1.2. Liquid
      • 9.3.1.3. Spray
  • 9.4. Middle East & Africa Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Retail Pharmacies
      • 9.4.1.3. Drug Stores
      • 9.4.1.4. Online Pharmacies
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.2. GCC Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.3. GCC Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.4. GCC Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.5. South Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.6. South Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.7. South Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.8. South Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.9. Egypt Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.10. Egypt Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.11. Egypt Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.12. Egypt Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.13. Nigeria Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.14. Nigeria Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.15. Nigeria Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.16. Nigeria Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Type vs by Drugs Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Abbott Laboratories
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Acella Pharmaceuticals, LLC
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. GlaxoSmithKline Plc
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Johnson & Johnson services Inc.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Merck KGaA
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Novartis International AG
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Pfizer Inc.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Procter & Gamble
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations